Health
Researchers develop ACE2 decoy to neutralise SARS-CoV-2 – Drug Target Review
Researchers have engineered human angiotensin converting enzyme 2 (hACE2) protein decoys that can protect cells from SARS-CoV-2.

Posted: 10 November 2020 | Hannah Balfour (Drug Target Review) | No comments yet
Using their de novo protein design strategy, researchers engineered human angiotensin converting enzyme 2 (hACE2) protein decoys that can protect cells from SARS-CoV-2 infection.
To infect cells within the respiratory tract, the Spike (S) protein on the surface of SARS-CoV-2 must bind to a receptor on human cells called angiotensin converting enzyme 2 (ACE2). The receptor binding domains (RBDs) are the section of the…
-
Noosa News23 hours ago
Reubhan Ralph identified as man behind terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
General21 hours ago
Police say new leads being pursued after baby’s body found in Alexander Heights stormwater drain
-
Noosa News24 hours ago
Schoolgirls hit by fishtailing car in terrifying crash in Bellbird Park, Ipswich
-
Noosa News21 hours ago
Police charge second man over alleged assault in Gold Coast car seller on Facebook’s Marketplace